Annual Statements Open main menu

5E Advanced Materials, Inc. - Quarter Report: 2023 March (Form 10-Q)

10-Q

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2023

or

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number 001-41279

5E ADVANCED MATERIALS, INC.

img211596162_0.jpg 

(Exact name of Registrant as specified in its Charter)

Delaware

87-3426517

(State or other jurisdiction of
incorporation or organization)

(I.R.S. Employer
Identification No.)

19500 State Highway 249, Suite 125

Houston, TX

77070

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code: (346) 439-9656

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading

Symbol(s)

Name of each exchange

on which registered

Common Stock, $0.01 par value

FEAM

The Nasdaq Global Select Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No

As of May 15, 2023, there were 44,149,172 shares of the Registrant’s common stock outstanding.

 

 


 

Table of Contents

Page

Part I - Financial Information

Item 1.

Financial Statements

3

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

16

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

21

Item 4.

Controls and Procedures

21

Part II - Other Information

Item 1.

Legal Proceedings

22

Item 1A.

Risk Factors

22

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

23

Item 3.

Defaults Upon Senior Securities

23

Item 4.

Mine Safety Disclosures

23

Item 5.

Other Information

23

Item 6.

Exhibits

24

Signatures

25

 

2


 

Part I - Financial Information

Item 1. Financial Statements.

5E ADVANCED MATERIALS, INC.

CONDENSED CONSOLIDATED BALANCE SHEET

(Unaudited)

(In thousands, except share data)

 

 

March 31,

 

 

June 30,

 

 

 

2023

 

 

2022

 

ASSETS

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

Cash and cash equivalents

 

$

36,170

 

 

$

31,057

 

Prepaid expenses and other current assets

 

 

1,892

 

 

 

1,506

 

Total current assets

 

 

38,062

 

 

 

32,563

 

Mineral rights and properties, net

 

 

7,612

 

 

 

8,364

 

Construction in progress

 

 

61,533

 

 

 

25,625

 

Properties, plant and equipment, net

 

 

3,084

 

 

 

2,871

 

Reclamation bond deposit

 

 

1,086

 

 

 

1,086

 

Right of use asset

 

 

247

 

 

 

371

 

Other assets

 

 

6

 

 

 

6

 

Total assets

 

$

111,630

 

 

$

70,886

 

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

Accounts payable and accrued liabilities

 

$

11,314

 

 

$

7,212

 

Lease liabilities, current

 

 

158

 

 

 

164

 

Total current liabilities

 

 

11,472

 

 

 

7,376

 

Long-term debt, net

 

 

36,228

 

 

 

148

 

Lease liabilities

 

 

94

 

 

 

211

 

Accrued reclamation liabilities

 

 

676

 

 

 

489

 

Total liabilities

 

 

48,470

 

 

 

8,224

 

 

 

 

 

 

 

 

Commitments and contingencies (Note 12)

 

 

 

 

 

 

 

 

 

 

 

 

 

Stockholders’ Equity:

 

 

 

 

 

 

Common stock, $0.01 par value; 180,000 shares authorized; 44,149 and
   
43,305 shares outstanding March 31 and June 30, respectively

 

 

441

 

 

 

433

 

Additional paid-in capital

 

 

190,455

 

 

 

169,593

 

Retained earnings (accumulated deficit)

 

 

(127,736

)

 

 

(107,364

)

Total stockholders’ equity

 

 

63,160

 

 

 

62,662

 

Total liabilities and stockholders’ equity

 

$

111,630

 

 

$

70,886

 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

3


 

5E ADVANCED MATERIALS, INC.

CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)

(Unaudited)

(In thousands, except per share amounts)

 

 

 

Three months ended March 31,

 

 

Nine Months Ended March 31,

 

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

Project expenses

 

$

1,268

 

 

$

2,039

 

 

$

8,267

 

 

$

9,816

 

General and administrative

 

 

6,004

 

 

 

30,832

 

 

 

18,591

 

 

 

44,497

 

Research and development

 

 

45

 

 

 

88

 

 

 

123

 

 

 

88

 

Impairment

 

 

908

 

 

 

 

 

 

908

 

 

 

 

Depreciation and amortization expense

 

 

53

 

 

 

36

 

 

 

132

 

 

 

76

 

Total operating expenses

 

 

8,278

 

 

 

32,995

 

 

 

28,021

 

 

 

54,477

 

Income (loss) from operations

 

 

(8,278

)

 

 

(32,995

)

 

 

(28,021

)

 

 

(54,477

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-operating income (expense):

 

 

 

 

 

 

 

 

 

 

 

 

Other income

 

 

13

 

 

 

29

 

 

 

49

 

 

 

39

 

Interest income

 

 

388

 

 

 

1

 

 

 

914

 

 

 

2

 

Derivative gain (loss)

 

 

 

 

 

 

 

 

11,743

 

 

 

 

Interest expense

 

 

(2,237

)

 

 

(1

)

 

 

(5,043

)

 

 

(2

)

Other income (expense)

 

 

(1

)

 

 

(3

)

 

 

(14

)

 

 

961

 

Total non-operating income (expense)

 

 

(1,837

)

 

 

26

 

 

 

7,649

 

 

 

1,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income (loss) before income taxes

 

 

(10,115

)

 

 

(32,969

)

 

 

(20,372

)

 

 

(53,477

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Income tax provision (benefit)

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss)

 

$

(10,115

)

 

$

(32,969

)

 

$

(20,372

)

 

$

(53,477

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) per common share — basic and diluted

 

$

(0.23

)

 

$

(0.79

)

 

$

(0.47

)

 

$

(1.33

)

Weighted average common shares outstanding — basic and diluted

 

 

44,104

 

 

 

41,895

 

 

 

43,737

 

 

 

40,148

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Comprehensive income (loss):

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss)

 

$

(10,115

)

 

$

(32,969

)

 

$

(20,372

)

 

$

(53,477

)

Reporting currency translation gain (loss)

 

 

 

 

 

(339

)

 

 

 

 

 

(1,169

)

Comprehensive income (loss)

 

$

(10,115

)

 

$

(33,308

)

 

$

(20,372

)

 

$

(54,646

)

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

4


 

 

5E ADVANCED MATERIALS, INC.

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

(Unaudited)

(In thousands)

 

 

For the nine months ended March 31,

 

 

 

2023

 

 

2022

 

 

 

 

 

Cash Flows From Operating Activities:

 

 

 

 

 

 

Net income (loss)

 

$

(20,372

)

 

$

(53,477

)

Adjustments to reconcile net income (loss) to net cash used by operating activities:

 

 

 

 

 

 

Depreciation and amortization

 

 

132

 

 

 

76

 

Share based compensation

 

 

4,251

 

 

 

4,428

 

Common stock issued for consulting fees

 

 

 

 

 

27,172

 

Unrealized (gain) loss on convertible note derivative instrument

 

 

(11,743

)

 

 

 

Impairment

 

 

908

 

 

 

 

Accretion of reclamation liability

 

 

20

 

 

 

6

 

Amortization of debt issuance costs and discount — convertible note

 

 

3,454

 

 

 

 

Amortization of right of use asset

 

 

124

 

 

 

 

Interest earned on reclamation bond

 

 

 

 

 

(1

)

Net foreign exchange (gain) loss

 

 

 

 

 

(965

)

Change in:

 

 

 

 

 

 

Prepaid expenses and other current assets

 

 

(386

)

 

 

(3,050

)

Accounts payable and accrued liabilities

 

 

(514

)

 

 

2,421

 

Net cash used in operating activities

 

 

(24,126

)

 

 

(23,390

)

Cash Flows From Investing Activities:

 

 

 

 

 

 

Construction in progress

 

 

(29,705

)

 

 

(3,301

)

Mineral rights and properties additions

 

 

 

 

 

(87

)

Properties, plant and equipment additions

 

 

(333

)

 

 

(1,222

)

Net cash used in investing activities

 

 

(30,038

)

 

 

(4,610

)

Cash Flows From Financing Activities:

 

 

 

 

 

 

Proceeds from issuance of convertible note

 

 

55,840

 

 

 

 

Payments on note payable

 

 

(29

)

 

 

(104

)

Proceeds from issuance of common stock

 

 

 

 

 

26,309

 

Share offering costs

 

 

 

 

 

(797

)

Proceeds from exercise of stock options

 

 

3,466

 

 

 

3,124

 

Net cash provided by financing activities

 

 

59,277

 

 

 

28,532

 

Net increase (decrease) in cash and cash equivalents

 

 

5,113

 

 

 

532

 

Effect of exchange rate fluctuation on cash

 

 

 

 

 

(203

)

Cash and cash equivalents at beginning of period

 

 

31,057

 

 

 

40,811

 

Cash and cash equivalents at end of period

 

$

36,170

 

 

$

41,140

 

 

 

 

 

 

 

 

Supplemental Disclosure of Cash Flow Information:

 

 

 

 

 

 

Cash paid for interest

 

$

5

 

 

$

 

 

 

 

 

 

 

 

Noncash Investing and Financing Activities:

 

 

 

 

 

 

Accounts payable and accrued liabilities change related to construction in progress

 

$

6,203

 

 

$

2,022

 

Interest paid through issuance of additional convertible notes

 

 

1,710

 

 

 

 

Equipment acquired with notes payable

 

 

 

 

 

227

 

Recognition of operating lease liability and right of use asset

 

 

 

 

 

137

 

Increase (decrease) in asset retirement costs

 

 

167

 

 

 

 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

5


 

5E ADVANCED MATERIALS, INC.

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY

(Unaudited)

(In thousands)

 

 

 

 

 

 

 

 

 

Additional

 

 

Accumulated

 

 

 

 

 

Total

 

 

 

Common Stock

 

 

Paid-in

 

 

Comprehensive

 

 

Accumulated

 

 

Stockholders'

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Income (loss)

 

 

Deficit

 

 

Equity

 

Balance at June 30, 2022

 

 

43,305

 

 

$

433

 

 

$

169,593

 

 

$

 

 

$

(107,364

)

 

$

62,662

 

Shares issued for:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercise of stock options

 

 

50

 

 

 

1

 

 

 

255

 

 

 

 

 

 

 

 

 

256

 

Share based compensation

 

 

 

 

 

 

 

 

1,300

 

 

 

 

 

 

 

 

 

1,300

 

Net income (loss)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4,606

 

 

 

4,606

 

Balance at September 30, 2022

 

 

43,355

 

 

 

434

 

 

 

171,148

 

 

 

 

 

 

(102,758

)

 

 

68,824

 

Shares issued for:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercise of stock options

 

 

525

 

 

 

5

 

 

 

1,911

 

 

 

 

 

 

 

 

 

1,916

 

Vesting of restricted share units

 

 

9

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Share based compensation

 

 

 

 

 

 

 

 

2,233

 

 

 

 

 

 

 

 

 

2,233

 

Convertible note derivative
    liability reclassification

 

 

 

 

 

 

 

 

13,153

 

 

 

 

 

 

 

 

 

13,153

 

Net income (loss)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(14,863

)

 

 

(14,863

)

Balance at December 31, 2022

 

 

43,889

 

 

$

439

 

 

$

188,445

 

 

$

 

 

$

(117,621

)

 

$

71,263

 

Shares issued for:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercise of stock options

 

 

260

 

 

 

2

 

 

 

1,292

 

 

 

 

 

 

 

 

 

1,294

 

Vesting of restricted share units

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Share based compensation

 

 

 

 

 

 

 

 

718

 

 

 

 

 

 

 

 

 

718

 

Net income (loss)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(10,115

)

 

 

(10,115

)

Balance at March 31, 2023

 

 

44,149

 

 

$

441

 

 

$

190,455

 

 

$

 

 

$

(127,736

)

 

$

63,160

 

 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

6


 

 

 

5E ADVANCED MATERIALS, INC.

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY

(Unaudited)

(In thousands)

 

 

 

 

 

 

 

 

 

Additional

 

 

Accumulated

 

 

 

 

 

Total

 

 

 

Common Stock

 

 

Paid-in

 

 

Comprehensive

 

 

Accumulated

 

 

Stockholders'

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Income (loss)

 

 

Deficit

 

 

Equity

 

Balance at June 30, 2021

 

 

38,391

 

 

$

384

 

 

$

101,180

 

 

$

1,417

 

 

$

(40,652

)

 

$

62,329

 

Shares issued for:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercise of stock options

 

 

303

 

 

 

3

 

 

 

1,083

 

 

 

 

 

 

 

 

 

1,086

 

Consulting fees

 

 

150

 

 

 

1

 

 

 

1,538

 

 

 

 

 

 

 

 

 

1,539

 

Share based compensation

 

 

 

 

 

 

 

 

1,776

 

 

 

 

 

 

 

 

 

1,776

 

Net income (loss)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(9,470

)

 

 

(9,470

)

Other comprehensive income (loss),
     net of tax

 

 

 

 

 

 

 

 

 

 

 

(1,606

)

 

 

 

 

 

(1,606

)

Balance at September 30, 2021

 

 

38,844

 

 

 

388

 

 

 

105,577

 

 

 

(189

)

 

 

(50,122

)

 

 

55,654

 

Shares issued for:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash

 

 

1,760

 

 

 

17

 

 

 

26,291

 

 

 

 

 

 

 

 

 

26,308

 

Exercise of stock options

 

 

865

 

 

 

9

 

 

 

1,813

 

 

 

 

 

 

 

 

 

1,822

 

Consulting fees

 

 

150

 

 

 

2

 

 

 

1,867

 

 

 

 

 

 

 

 

 

1,869

 

Share issuance costs

 

 

 

 

 

 

 

 

(797

)

 

 

 

 

 

 

 

 

(797

)

Share based compensation

 

 

 

 

 

 

 

 

1,311

 

 

 

 

 

 

 

 

 

1,311

 

Net income (loss)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(11,038

)

 

 

(11,038

)

Other comprehensive income (loss),
     net of tax

 

 

 

 

 

 

 

 

 

 

 

776

 

 

 

 

 

 

776

 

Balance at December 31, 2021

 

 

41,619

 

 

$

416

 

 

$

136,062

 

 

$

587

 

 

$

(61,160

)

 

$

75,905

 

Shares issued for:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercise of stock options

 

 

100

 

 

 

1

 

 

 

215

 

 

 

 

 

 

 

 

 

216

 

Consulting fees

 

 

800

 

 

 

8

 

 

 

23,756

 

 

 

 

 

 

 

 

 

23,764

 

Share based compensation

 

 

 

 

 

 

 

 

1,341

 

 

 

 

 

 

 

 

 

1,341

 

Net income (loss)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(32,969

)

 

 

(32,969

)

Other comprehensive income (loss),
     net of tax

 

 

 

 

 

 

 

 

 

 

 

(339

)

 

 

 

 

 

(339

)

Balance at March 31, 2022

 

 

42,519

 

 

$

425

 

 

$

161,374

 

 

$

248

 

 

$

(94,129

)

 

$

67,918

 

 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

7


 

5E ADVANCED MATERIALS, INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL

STATEMENTS

1. Basis of Financial Statement Presentation

These unaudited condensed consolidated financial statements (herein after referred to as “financial statements”) have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and should be read in the context of the consolidated financial statements and footnotes thereto for the year ended June 30, 2022 included in our annual report filed with the Securities and Exchange Commission on Form 10-K, as amended. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation of our financial position as of March 31, 2023, results of operations for the three and nine months ended March 31, 2023 and 2022 and cash flows for the nine months ended March 31, 2023 and 2022 have been included. Operating results for the three and nine months ended March 31, 2023 are not necessarily indicative of the results that may be expected for the full fiscal year ending June 30, 2023.

Basis of Consolidation

The unaudited condensed consolidated financial statements comprise the financial statements of 5E Advanced Materials, Inc. and its wholly owned subsidiaries, American Pacific Borates Pty Ltd. and 5E Boron Americas, LLC (formerly Fort Cady (California) Corporation), (collectively, “5E,” “we,” “our,” “us” or the “Company”).

Going Concern

 

We evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about our ability to continue as a going concern within one year after the date that these consolidated financial statements are issued. This evaluation initially does not take into consideration the potential mitigating effect of management’s plans that have not been fully implemented as of the date the financial statements are issued. When substantial doubt exists under this methodology, we evaluate whether the mitigating effect of our plans sufficiently alleviates substantial doubt about our ability to continue as a going concern. The mitigating effect of our plans, however, is only considered if both (1) it is probable that the plans will be effectively implemented within one year after the date that the financial statements are issued, and (2) it is probable that the plans, when implemented, will mitigate the relevant conditions or events that raise substantial doubt about the entity’s ability to continue as a going concern within one year after the date that these consolidated financial statements are issued. In performing our analysis, we excluded certain elements of our operating plan that cannot be considered probable. The future receipt of potential funding from equity or debt issuances cannot be considered probable at this time because these plans are not entirely within our control as of the date of these consolidated financial statements. As discussed in Note 7, the Convertible Note contains a financial covenant requiring us to maintain a cash balance of at least $10 million. Our available liquidity is expected to fall below $10 million in the latter part of calendar year 2023 based on our most recently updated modified business plan, which includes an increase in Small-Scale Facility costs due to increases in third-party construction cost estimates. If we are not able to obtain additional financing and our cash balance falls below $10 million, an event of default under the Convertible Note agreement would occur if not cured within 30 days.

Our plans include reduced spending and the pursuit of additional capital. Given that raising additional capital is not entirely within our control combined with our expectation of incurring significant operating and development costs in the foreseeable future, there exists substantial doubt regarding our ability to continue as a going concern for a period of one year after the date that these financial statements are issued.

 

These financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the ordinary course of business and do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might result from the outcome of the uncertainties described above.

Risk and Uncertainties

We are subject to a number of risks that we believe are similar to those of other companies of similar size in our industry, including but not limited to, the success of our exploration activities, need for significant additional capital (or financing) to fund operating losses, competition from substitute products and services from larger companies, protection of proprietary technology, patent litigation, and dependence on key individuals. We currently generate no revenues from operations and will need to rely on raising additional capital or financing to sustain operations in the long-term. There can be no assurance that we will be successful in our efforts to raise additional capital on terms favorable to us, or at all, or our ability to adequately reduce expenses, if necessary, to maintain sufficient liquidity or capital resources.

8


 

We expect our available liquidity will fall below $10 million within the next 12 months. If we are not able to secure additional financing and our cash balance falls below $10 million, an event of default under a Convertible Note indenture would occur if not cured within 30 days. An event of default would cause our Convertible Note balance outstanding to become immediately due and payable, of which we would not have the resources to repay without additional financing.

Significant Accounting Policies

Convertible Debt

Upon the issuance of convertible debt, we evaluate the embedded conversion features to determine whether the embedded conversion feature(s) should be bifurcated from the host instrument and accounted for separately as a derivative. If the conversion feature does not require derivative treatment, the instrument is evaluated for consideration of any beneficial conversion features. If a conversion feature is deemed to be beneficial, the intrinsic value of the conversion feature is recorded as additional paid in capital.

Derivative Financial Instruments

We record derivative instruments on the balance sheet at fair value as either an asset or a liability with changes in fair value recognized currently in earnings. The related cash flow impact of our derivative activities is reflected as cash flows from operating activities unless the derivatives are determined to have a significant financing element at inception, in which case they are classified within financing activities.

Debt Issue Costs

Costs incurred in connection with the issuance of debt are recorded as a reduction of the related debt and are amortized to interest expense over the life of the debt. If a conversion of the underlying debt occurs, a proportionate share of the unamortized amount is expensed in the period of conversion.

 

Fair Value Measurements

Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). The authoritative guidance requires disclosure of the framework for measuring fair value and requires that fair value measurements be classified and disclosed in one of the following categories:

Level 1 - Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities. We consider active markets as those in which transactions for the assets or liabilities occur with sufficient frequency and volume to provide pricing information on an ongoing basis.

Level 2 - Quoted prices in markets that are not active, or inputs that are observable, either directly or indirectly, for substantially the full term of the asset or liability. This category includes those derivative instruments that can be valued using observable market data. Substantially all of the inputs are observable in the marketplace throughout the full term of the derivative instrument, can be derived from observable data, or are supported by observable levels at which transactions are executed in the marketplace.

Level 3 - Measured based on prices or valuation models that require inputs that are both significant to the fair value measurement and less observable from objective sources (i.e., supported by little or no market activity).

Financial assets and liabilities are classified based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement requires judgment and may affect the valuation of the fair value of assets and liabilities and their placement within the fair value hierarchy. We periodically review our inputs to ensure the fair value level classification is appropriate. When transfers between levels occur, it is our policy to assume that the transfer occurred at the end of the period in which the change in circumstances that caused the transfer occurred.

Reclassifications

Certain reclassifications have been made to prior years’ reported amounts in order to conform to the current year presentation. These reclassifications did not impact our previously reported net income (loss), stockholders’ equity or cash flows.

Recently Issued and Adopted Accounting Pronouncements

In August 2020, FASB issued ASU No. 2020-06–Debt–Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. The update is to address issues identified as a result of the complexity associated with applying GAAP for certain financial instruments with characteristics of liabilities and equity. We adopted this standard during the quarter ended September 30, 2022. The adoption of this standard did not have an effect on our previously reported consolidated financial statements

9


 

as we had no transactions that were the subject of the pronouncement. During the quarter ended September 30, 2022, we issued convertible debt and accounted for it in accordance with the updates provided for by ASU No. 2020-06.

In May 2021, FASB issued ASU No. 2021-04—Earnings Per Share (Topic 260), Debt— Modifications and Extinguishments (Subtopic 470-50), Compensation—Stock Compensation (Topic 718), and Derivatives and Hedging— Contracts in Entity’s Own Equity (Subtopic 815-40) Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options. The update is to clarify and reduce diversity in accounting for modifications or exchanges of freestanding equity-classified written call options (for example, warrants) that remain equity classified after modification or exchange. The adoption of this standard during the quarter ended September 30, 2022 did not have an effect on our consolidated financial statements.

2. Mineral Rights and Properties, Net

Mineral rights and properties, net consisted of the following.

 

 

March 31,

 

 

June 30,

 

 

 

2023

 

 

2022

 

 

 

(in thousands)

 

Mineral properties

 

$

6,733

 

 

$

6,733

 

Hydrology wells

 

 

547

 

 

 

547

 

Mineral interest – Elementis lease(1)

 

 

 

 

 

908

 

Asset retirement cost, net of accumulated amortization
   of $
17 and $6 at March 31, 2023 and June 30, 2022, respectively(2)

 

 

332

 

 

 

176

 

Mineral rights and properties, net

 

$

7,612

 

 

$

8,364

 

 

(1)
During the quarter ended March 31, 2023, we elected not to renew our mineral lease with Elementis Specialties, Inc. and the mineral lease expired on March 31, 2023 resulting in the recognition of approximately $908 thousand of related impairment expense during the current quarter.
(2)
Asset retirement costs represent the carrying value of capitalized costs associated with asset retirement obligations discussed in Note 5.

3. Construction in Progress

Construction in progress consisted of the following.

 

 

March 31,

 

 

June 30,

 

 

 

2023

 

 

2022

 

 

 

(in thousands)

 

Engineering services

 

$

9,119

 

 

$

8,656

 

Equipment

 

 

28,768

 

 

 

13,548

 

Construction services

 

 

19,248

 

 

 

 

Injection and recovery wells

 

 

3,809

 

 

 

3,421

 

Capitalized interest

 

 

589

 

 

 

 

Total construction in progress

 

$

61,533

 

 

$

25,625

 

 

4. Properties, Plant and Equipment, Net

Properties, plant and equipment, net consisted of the following.

 

 

 

Depreciation

 

Estimated useful

 

March 31,

 

 

June 30,

 

Asset category

 

method

 

life (in years)

 

2023

 

 

2022

 

 

 

 

 

 

 

(in thousands)

 

Land

 

N/A

 

 

$

1,533

 

 

$

1,533

 

Buildings

 

Straight-line

 

7-15

 

 

873

 

 

 

873

 

Vehicles

 

Straight-line

 

3-5

 

 

344

 

 

 

276

 

Plant and equipment

 

Straight-line

 

5-10

 

 

604

 

 

 

340

 

 

 

 

 

 

 

3,354

 

 

 

3,022

 

Less accumulated depreciation

 

 

 

 

 

 

(270

)

 

 

(151

)

Properties, plant and equipment, net

 

 

 

 

 

$

3,084

 

 

$

2,871

 

For the three and nine months ended March 31, 2023 and 2022, we recognized depreciation expense of approximately $46.7 and $119 thousand, and $34.1 and $72.4 thousand, respectively.

 

.

 

10


 

5. Reclamation Liabilities

The change in our ARO during the periods presented, and the balance of our accrued reclamation liabilities at the end of each period is set forth below.

 

 

March 31,

 

 

June 30,

 

 

 

2023

 

 

2022

 

 

 

(in thousands)

 

Asset retirement obligation — beginning of period

 

$

191

 

 

$

79

 

Obligation incurred during the period

 

 

 

 

 

106

 

Revisions to previous estimates

 

 

167

 

 (1)

 

(3

)

Accretion

 

 

20

 

 

 

9

 

Asset retirement obligation — end of period

 

 

378

 

 

 

191

 

Accrued reclamation costs

 

 

298

 

 

 

298

 

Total accrued reclamation liabilities

 

$

676

 

 

$

489

 

(1) attibutable to revised cost estimates provided by a third-party engineering firm and is reflected as an increase to mineral rights and properties (see Note 2).

 

Accrued reclamation costs of $298 thousand relate to surface reclamation obligations at Fort Cady.

6. Accounts Payable and Accrued Liabilities

Accounts payable and accrued liabilities consisted of the following at the end of each period presented.

 

 

March 31,

 

 

June 30,

 

 

 

2023

 

 

2022

 

 

 

(in thousands)

 

Accounts payable - trade (1)

 

$

4,309

 

 

$

3,459

 

Accrued expenses

 

 

451

 

 

 

1,584

 

Accrued capital expenditures

 

 

4,893

 

 

 

1,351

 

Accrued payroll

 

 

1,158

 

 

 

780

 

Accrued interest

 

 

463

 

 

 

 

Current portion of debt

 

 

40

 

 

 

38

 

Accounts payable and accrued liabilities

 

$

11,314

 

 

$

7,212

 

(1) includes $3.8 million and $1.6 million related to capital expenditures, respectively

 

7. Long-term Debt

Long-term debt consisted of the following at the end of each period presented.

 

 

March 31,

 

 

June 30,

 

 

 

2023

 

 

2022

 

 

 

(in thousands)

 

Convertible note

 

$

61,710

 

 

$

 

Vehicle notes payable

 

 

158

 

 

 

186

 

Total debt

 

 

61,868

 

 

 

186

 

Current portion of debt

 

 

40

 

 

 

38

 

Long-term debt

 

 

61,828

 

 

 

148

 

Unamortized convertible note discount — embedded conversion feature

 

 

(21,936

)

 

 

 

Unamortized debt issuance costs - convertible note

 

 

(3,664

)

 

 

 

Long-term debt, net

 

$

36,228

 

 

$

148

 

At March 31, 2023 the fair value of the convertible note was $39.7 million.

 

11


 

Interest expense consisted of the following.

 

 

Nine months ended March 31,

 

 

 

2023

 

 

2022

 

 

 

(in thousands)

 

Convertible note interest

 

$

2,173

 

 

$

 

Notes payable interest

 

 

 

 

 

2

 

Vehicle notes payable interest

 

 

5

 

 

 

 

Amortization of debt issuance costs and discount — convertible note

 

 

3,454

 

 

 

 

Gross interest expense

 

 

5,632

 

 

 

2

 

Less: amount capitalized to construction in progress

 

 

589

 

 

 

 

Interest expense, net of amounts capitalized

 

$

5,043

 

 

$

2

 

 

 

 

 

 

 

 

 Effective interest rate — convertible note

 

 

26.21

%

 

 

 

Convertible Note

On August 11, 2022, we executed a $60 million private placement of Senior Secured Convertible Note (“the Note” or "Convertible Note"), with Bluescape Energy Partners (“Bluescape”). The Note, which is convertible into our common stock and matures in August 2027, closed on August 26, 2022. At our election, the Note bears interest at an annual rate of 4.50% if paid in cash, or at an annual rate of 6.00% if paid through the issuance of additional notes and contains a financial covenant requiring us to maintain a cash balance of at least $10 million. The purchaser may convert the Note at any time before August 2027 at a conversion price of $17.60 (“Conversion Price”). We have the right, at any time on or before the twenty-four (24) month anniversary of the closing date of the Note (“Closing Date”), to convert the Note to our common stock in whole or in part if the closing price of our common stock is at least 200% of the Conversion Price of the Note (“Threshold Price”) for each of the twenty (20) consecutive trading days prior to the time we deliver a conversion notice. The Threshold Price for our right to convert the Note decreases to 150% after the twenty-four (24) month anniversary of the Closing Date and on or before the thirty-six (36) month anniversary of the Closing, and to 130% at any time after the thirty-six (36) month anniversary of the Closing Date.

On February 15, 2023 we elected to issue additional notes as payment for $1.7 million of interest accrued during the period August 26, 2022 through February 15, 2023.

Due to a provision in the Convertible Note agreement that allowed for a change in the conversion price upon a digressive issuance by us within three months of the closing date, the conversion feature of the Note was deemed an embedded derivative requiring separate accounting as a stand-alone derivative instrument (convertible note derivative). The Note was recorded at its face amount of $60 million less debt issuance costs of $4.2 million and the fair value of the convertible note derivative of $24.9 million. Fair value information for the convertible instrument follows. The provision resulting in the separate derivative accounting for the conversion feature expired November 26, 2022, and accordingly, the fair value of the convertible note derivative at expiration of the provision was transferred to additional paid-in capital (see Note 8).

 

 

 

 

 

August 26,

 

 

 

November 26,

 

 

2022

 

 

 

2022

 

 

(Inception)

 

 

 

(in thousands)

 

Fair value of convertible note (Level 2)

 

$

36,388

 

 

$

35,104

 

Fair value of embedded conversion feature (Level 3)

 

 

13,153

 

 

 

24,896

 

Total fair value of convertible note instrument

 

$

49,541

 

 

$

60,000

 

 

 

12


 

8. Convertible Note Derivative

The convertible note derivative, which related to the Convertible Note described above, was valued upon initial recognition at fair value using a with-and-without methodology utilizing a binomial lattice model (Level 3). Changes in fair value were recognized in the statement of operations prior to the derecognition of the convertible note derivative during the quarter ended December 31, 2022. As described above in Note 7, the fair value of the convertible note derivative was transferred to additional paid-in capital during the three months ended December 31, 2022. The components of changes to the fair value of the convertible note derivative are summarized below.

 

 

(in thousands)

 

Convertible note derivative — June 30, 2022

 

$

 

Additions

 

 

24,896

 

Fair value adjustment (gain)

 

 

(11,743

)

Reclassified to additional paid-in capital

 

 

(13,153

)

Convertible note derivative — March 31, 2023

 

$

 

The valuation model requires the input of subjective assumptions including expected share price volatility, risk-free interest rate and debt rate. Changes in the input assumptions as well as our underlying share price can materially affect the fair value estimate and reported net income (loss). The assumptions used in the valuation model include the following, with a change in volatility and debt rate having the most significant impact on the valuation.

 

 

November 26,

 

 

 

August 26,

 

 

2022

 

September 30,

 

2022

 

 

(Termination)

 

2022

 

(Inception)

Risk-free interest rate

 

3.9%

 

4.1%

 

3.2%

Volatility

 

40.0%

 

40.0%

 

40.0%

Debt rate

 

17.7%

 

18.6%

 

17.3%

 

9. Financial Instruments and Fair Value Measurements

 

At March 31, 2023, cash equivalents as well as trade and other payables approximate their fair value due to their short-term nature. Our financial instruments also consist of environmental reclamation bonds which are invested in certificates of deposit and money market funds which are classified as Level 1, and the convertible note derivative which was classified as Level 3 before its derecognition and transfer to additional paid-in capital during the current period. The reconciliation of changes in the fair value of liabilities classified as Level 3 can be found in Notes 7 and 8.

 

10. Share Based Compensation

Share based compensation expense is included in general and administrative expense and consisted of the following for the periods presented.

 

 

 

Three months ended March 31,

 

 

Nine months ended March 31,

 

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

 

 

(in thousands)

 

Share based compensation expense — service based

 

 

 

 

 

 

 

 

 

 

 

 

Employee share option plan

 

$

617

 

 

$

1,343

 

 

$

2,839

 

 

$

4,179

 

2022 Equity Compensation Plan — Options

 

 

350

 

 

 

 

 

 

877

 

 

 

 

2022 Equity Compensation Plan — PSU's

 

 

29

 

 

 

 

 

 

88

 

 

 

 

2022 Equity Compensation Plan — RSU and DSU's

 

 

(278

)

 

 

 

 

 

447

 

 

 

 

Total service based compensation

 

 

718

 

 

 

1,343

 

 

 

4,251

 

 

 

4,179

 

Options issued to suppliers

 

 

 

 

 

 

 

 

 

 

 

249

 

Consulting stock awards

 

 

 

 

 

23,764

 

 

 

 

 

 

27,172

 

Total share based compensation expense

 

$

718

 

 

$

25,107

 

 

$

4,251

 

 

$

31,600

 

 

13


 

Stock Options

All options outstanding prior to the three-month period ended September 30, 2022 were granted under our predecessor parent company's employee share option plan. New option grants are made under the 2022 Equity Compensation Plan and vest ratably over three years. The tables below reflect all options granted under both plans. The significant assumptions used to estimate the fair value of stock option awards granted under the plans during the nine months ended March 31, 2023 and 2022, using the Black-Scholes option valuation model are as follows.

 

 

 

Nine months ended March 31,

 

 

2023

 

2022

Exercise price

 

$25.62

 

$14.62 - $18.27

Share price

 

$18.03

 

$12.43

Volatility

 

79%

 

85%

Expected term in years

 

5

 

0.9 to 3.9

Risk-free interest rate

 

2.91%

 

0.01% - 0.1%

Dividend rate

 

Nil

 

Nil

 

The following table summarizes stock option activity for each of the periods presented.

 

 

 

Nine months ended March 31,

 

 

 

2023

 

 

2022

 

 

 

Number of Options

 

 

Weighted Average Exercise Price

 

 

Number of Options

 

 

Weighted Average Exercise Price

 

 

 

(In thousands, except per share data)

 

Outstanding at beginning of the period

 

 

4,874

 

 

$

9.67

 

 

 

5,554

 

 

$

5.19

 

Granted

 

 

400

 

 

 

25.62

 

 

 

1,700

 

 

 

15.39

 

Exercised

 

 

(835

)

 

 

4.15

 

 

 

(1,267

)

 

 

2.48

 

Expired/forfeited

 

 

(460

)

 

 

15.33

 

 

 

(477

)

 

 

5.48

 

Outstanding at end of the period

 

 

3,979

 

 

 

11.78

 

 

 

5,510

 

 

 

8.94

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Vested at the end of the period

 

 

3,186

 

 

$

9.58

 

 

 

3,870

 

 

$

6.39

 

Unvested at the end of the period

 

 

793

 

 

 

20.63

 

 

 

1,640

 

 

 

14.95

 

 

The weighted average remaining life of vested options at March 31, 2023 and 2022 was 1.65 years and 2.03 years, respectively.

As of March 31, 2023, there was $4.6 million of unrecognized compensation cost related to 793 thousand unvested stock options. This cost is expected to be recognized over a weighted-average remaining period of approximately 1.6 years.

The following table summarizes the activity for unvested options for each of the periods presented.

 

 

Nine months ended March 31,

 

 

 

2023

 

 

2022

 

 

 

Number of Options

 

 

Weighted Average Grant Date Fair Value per share

 

 

Number of Options

 

 

Weighted Average Grant Date Fair Value per share

 

 

 

(In thousands, except per share data)

 

Unvested at beginning of the period

 

 

1,507

 

 

$

6.05

 

 

 

270

 

 

$

5.79

 

Granted

 

 

400

 

 

 

10.52

 

 

 

1,700

 

 

 

6.26

 

Vested

 

 

(1,014

)

 

 

5.86

 

 

 

(330

)

 

 

7.13

 

Expired/forfeited

 

 

(100

)

 

 

6.85

 

 

 

 

 

 

8.11

 

Unvested at end of the period

 

 

793

 

 

 

8.32

 

 

 

1,640

 

 

 

6.01

 

As of March 31, 2023, the intrinsic value of both the outstanding stock options and vested options was $1.3 million. The intrinsic value of stock options exercised during the nine months ended March 31, 2023 and 2022 was $6.2 million and $14.4 million, respectively.

14


 

 

Restricted Share Units, Director Share Units and Performance Share Units

The following table summarizes restricted share ("RSU"), director restricted share ("DSU") and performance share ("PSU") activity under the 2022 Equity Compensation Plan for each of the periods presented.

 

 

Serviced-Based Shares

 

 

Weighted Average Grant Date Fair Value per Share

 

 

Performance- Based Shares

 

 

Weighted Average Grant Date Fair Value per Unit

 

 

Total Shares

 

 

 

(In thousands, except per share data)

 

Non-vested shares/units outstanding
   at July 1, 2022

 

 

48.8

 

 

$

18.03

 

 

 

19.2

 

 

$

12.19

 

 

 

68.0

 

Granted

 

 

106.5

 

 

 

14.47

 

 

 

63.5

 

(2)

 

14.79

 

 

 

170.0

 

Vested

 

 

(8.9

)

 

 

12.27

 

 

 

 

 

 

 

 

 

(8.9

)

Forfeited

 

 

(47.9

)

 

 

14.27

 

 

 

(42.5

)

 

 

14.10

 

 

 

(90.4

)

Non-vested shares/units outstanding
   at March 31, 2023

 

 

98.5

 

(1)

$

16.53

 

 

 

40.2

 

 

$

14.28

 

 

 

138.7

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) Includes approximately 32 thousand director share units

 

(2) On September 1, 2022, we granted approximately 63.5 thousand performance share units, which based on the achievement of certain operational targets, could vest within a range of 0% to 100%. The operational targets are; 1) commissioning and operation of the small-scale facility; 2) obtaining formation flow, head grade and impurity profile data from the small-scale facility; and 3) generating product data to ensure process design for detailed engineering. The determination of the percentage of shares that ultimately vest will be made at the three-year anniversary of the grant date based upon achievement of the performance targets over the period.

 

 

 

 

11. Earnings (Loss) Per Common Share

Basic earnings (loss) per share (EPS) is calculated by dividing net income (loss) less any applicable adjustments (the numerator) by the weighted-average number of shares of common stock (excluding unvested restricted stock units) outstanding during the period (the denominator). Diluted EPS incorporates the dilutive impact of outstanding stock options and unvested restricted stock units (using the treasury stock method). Under the treasury stock method, the amount the employee must pay for exercising stock options, the amount of unrecognized compensation expense related to unvested restricted stock units and the amount of excess tax benefits that would be recorded when the award becomes deductible are assumed to be used to repurchase shares.

Diluted earnings (loss) per share equals basic loss per share as the inclusion of normally dilutive options and restricted stock units would be antidilutive due to reported net losses for those periods. For the nine months ended March 31, 2023 and 2022 respectively, stock options and unvested restricted stock units of 4,769 and 5,040 were excluded from the computation of diluted earnings (loss) per share.

12

12. Commitments and Contingencies

 

We had purchase order commitments of $16.2 million for the construction works in progress, equipment, software, drilling, and technical reports of which approximately $8.7 million is reflected in accounts payable and accrued liabilities on our balance sheet at March 31, 2023.

 

15


 

References herein to the “Company,” “we,” “our,” and “us,” refer to 5E Advanced Materials, Inc. and its subsidiaries.

CAUTIONARY NOTICE REGARDING FORWARD-LOOKING STATEMENTS

Certain statements included in this Quarterly Report on Form 10-Q for the three months ended March 31, 2023 (this “Form 10-Q”) contain various forward-looking statements relating to the Company’s future financial performance and results, financial condition, business strategy, plans, goals and objectives, including certain projections, business trends and other statements that are not historical facts. These statements constitute forward-looking statements within the meaning of the Safe Harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements generally are identified by the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “budget,” “target,” “aim,” “strategy,” “estimate,” “plan,” “guidance,” “outlook,” “intend,” “may,” “should,” “could,” “will,” “would,” “will be,” “will continue,” “will likely result” and similar expressions, although not all forward-looking statements contain these identifying words. Forward-looking statements reflect the Company’s beliefs and expectations based on current estimates and projections. While the Company believes these expectations, and the estimates and projections on which they are based, are reasonable and were made in good faith, these statements are subject to numerous risks and uncertainties. Forward-looking statements involve known and unknown risks, uncertainties and other important factors, which include, but are not limited to, the risks described under the heading “Risk Factor Summary” and “Item 1A. – Risk Factors” in our annual report on Form 10-K, any of which could cause the Company’s actual results, performance or achievements, or industry results, to differ materially from any future results, performance or achievements expressed or implied by such forward-looking statements. Therefore, you should not rely on any of these forward-looking statements.

These forward-looking statements speak only as of the date of this Form 10-Q and, except as required by law, the Company undertakes no obligation to correct, update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except to the extent required under federal securities laws. You are advised, however, to consult any additional disclosures we make in our reports to the U.S. Securities and Exchange Commission (the “SEC”). All subsequent written and oral forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the cautionary statements contained in our latest annual report on Form 10-K and this Form 10-Q.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

The following discussion and analysis of financial condition, results of operations, liquidity and capital resources should be read in conjunction with, and is qualified in its entirety by, the unaudited Condensed Consolidated Financial Statements and the notes thereto included in this Quarterly Report on Form 10-Q, and the Consolidated Financial Statements and notes thereto and Management’s Discussion and Analysis of Financial Condition and Results of Operations contained in the Annual Report on Form 10K filed on September 28, 2022. This discussion and analysis contains forward looking statements that involve risks, uncertainties and assumptions and other important factors, which include, but are not limited to, the risks described in our annual report on Form 10-K filed with the SEC, any of which could cause the Company’s actual results, performance or achievements, or industry results, to differ materially from any future results, performance or achievements expressed or implied by such forward-looking statements. The actual results may differ materially from those anticipated in these forward-looking statements as a result of certain factors, including, but not limited to, those set forth elsewhere in this Form 10-Q and under “Item 1A. Risk Factors” and elsewhere in our Form 10-K. In addition, see “Cautionary Note Regarding Forward-Looking Statements.” References to the “Company,” “we,” “our,” and “us,” refer to 5E Advanced Materials, Inc. and its subsidiaries.

 

16


 

Overview

5E Advanced Materials, Inc. is focused on becoming a vertically integrated global leader and supplier of boron specialty and advanced materials whose mission is to enable decarbonization, increase food security, and ensure domestic supply of critical materials. We hold 100% of the rights through ownership in the 5E Boron Americas (Fort Cady) Complex (the “Project”) located in southern California, through our wholly owned subsidiary 5E Boron Americas, LLC. Our Project is underpinned by a mineral resource that includes boron and lithium, with the boron being contained in a conventional boron mineral known as colemanite. In 2022, our facility was designated as Critical Infrastructure by the Department of Homeland Security’s Cybersecurity and Infrastructure Security Agency. Our vision is to safely process boric acid and lithium carbonate through sustainable best practices to enable decarbonization, food security and domestic supply surety.

2023 Outlook and Goals

Small-Scale Facility

During the quarter ended March 31, 2023, we have substantially completed construction of our Small-Scale Facility and progressed commissioning activities. Initial production of boric acid can commence upon final clearance from the U.S. Environmental Protection Agency (EPA) under our Underground Injection Control Permit as well as successful completion of commissioning activities. Key required reports and documentation were submitted to the EPA for their approval in 2022 and we believe we are in full compliance with the terms of the permit. Upon final review of required documentation by the EPA, we expect to receive authorization to commence mining operations. Data gathered from the construction and future operation of the Small-Scale Facility will be used to optimize and improve accuracy of our capital and operating estimates for our larger-scale operations, provide customer samples for qualification and future off-take agreements, and offset future operating expenses.

Technical Report Update and Larger Scale Facility Target

During the quarter, our team spent significant time completing an update to our initial assessment Technical Report Summary, which has been filed with the Securities and Exchange Commission. A dedicated internal and external team pooled their professional and technical expertise to publish a report that we believe demonstrates a world-class resource, management's firm understanding and direction for the business, and a phased approach to scale production, which can position the company to achieve profitability, generate cash flow, and reduce risk. The updated initial assessment includes a a revised mineral resource estimate for boric acid and lithium carbonate, estimates for capital costs and operating expenses, and a bottoms-up economic analysis based on a phased approach to scaling production. The financial model for the economic analysis includes preliminary market studies and independent pricing forecasts for boric acid and lithium carbonate. As part of our updated technical report, we engaged two external EPC firms to assist management with our capital cost estimate, which we expect to use as the basis to stage a formal process to request proposals for detail design of the large-scale facility.

The updated Technical Report Summary outlines three phases for the larger-scale facility:

Phase 1 targets production of 90,000 short tons of boric acid and 1,100 short tons of lithium carbonate with a targeted go-live date of the second calendar quarter of 2026.
Phase 2 and Phase 3 targets incremental production increases of 180,000 short tons of boric acid and 2,200 short tons of lithium carbonate in each phase with a targeted go live date in the fourth calendar quarter of 2028 (Phase 2) and second calendar quarter of 2031 (Phase 3).
Full operation includes targeting 450,000 short tons of boric acid and 5,500 short tons of lithium carbonate per annum.

CEO Appointment

During the quarter, we announced the appointment of Ms. Susan Seilheimer Brennan as our new Chief Executive Officer. Ms. Brennan started on April 24, 2023 and has an extensive global leadership background, particularly in the battery technology and electric vehicle industries. During Ms. Brennan's first two weeks, she has implemented general, administrative and fixed cost cutting measures and will relocate the Company's headquarters to California in an effort to focus on production of boric acid and lithium carbonate.

 

17


 

Highlights for the Three Months Ended March 31, 2023

Construction of the Small-Scale Facility substantially completed and operation pending authorization from EPA;
Continued track record of zero lost time incidents with over 175,000 man hours recorded;
Completion of update to initial assessment technical report with estimates for capital costs and operating expenses; and
Appointment of new CEO, Ms. Susan Seilheimer Brennan.

Liquidity

Our latest liquidity forecast indicates that available cash resources are expected to be exhausted in the next 12 months. We are actively exploring various financing options. However, if additional financing is not secured and our cash balance falls below $10 million, an event of default under the Convertible Note indenture would occur if not cured within 30 days. An event of default would cause our Convertible Note balance outstanding to become immediately due and payable, of which we would not have the resources to repay without additional financing. While we believe the that our plan to obtain sufficient funding will be successful, it is not entirely within our control and accordingly there is substantial doubt regarding our ability to continue as a going concern for a period of one year after the date that these unaudited condensed consolidated financial statements are issued. See Note 1 - "Going Concern" in the notes to the unaudited condensed consolidated financial statements and “Liquidity and Capital Resources” below for more information.

Inflation

The U.S. inflation rate has been steadily increasing since 2021 and into 2023. These inflationary pressures have resulted in and may result in additional increases to the cost of our goods, services, and personnel, which in turn cause our capital expenditures and labor costs to rise, including the estimated costs for our reclamation activities. Sustained levels of high inflation have caused the U.S. Federal Reserve and other central banks to increase interest rates, which could have the effects of raising the cost of capital and depressing economic growth, either of which or the combination thereof, could adversely affect our business.

COVID-19 Response

We have implemented policies at our offices in Houston, TX and Hesperia, CA as well as our project site in Newberry Springs, CA designed to ensure the safety and well-being of all employees and the people associated with them. In that regard, to reduce risk, our employees have been encouraged to get fully vaccinated against COVID-19, have been asked to work remotely at times, avoid non-essential business travel when applicable, adhere to good hygiene practices, and engage in social distancing. Continuation of COVID-19 in 2023 and beyond could impact employee health, workforce productivity, insurance premiums, ability to travel, the availability of industry experts, personnel and equipment, restrictions or delays to field work, construction, procurement, studies, lab results, and other factors that will depend on future developments that may be beyond our control.

The forward-looking information contained in this section is subject to the risk factors and assumptions contained in the “Cautionary Note Regarding Forward-Looking Statements” and “Risk Factor” sections.

18


 

Results of Operations

The following table summarizes our results of operations for the periods presented:

 

 

Three Months Ended March 31, 2023

 

 

Change

 

 

Nine Months Ended March 31, 2023

 

 

Change

 

 

2023

 

 

2022

 

 

$

 

 

%

 

 

2023

 

 

2022

 

 

$

 

 

%

 

 

($ in thousands)

 

COSTS AND EXPENSES

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Project expenses

$

1,268

 

 

$

2,039

 

 

$

(771

)

 

 

-38

%

 

$

8,267

 

 

$

9,816

 

 

$

(1,549

)

 

 

-16

%

General and administrative

 

6,004

 

 

 

30,832

 

 

 

(24,828

)

 

 

-81

%

 

 

18,591

 

 

 

44,497

 

 

 

(25,906

)

 

 

-58

%

Research and development

 

45

 

 

 

88

 

 

 

(43

)

 

 

-49

%

 

 

123

 

 

 

88

 

 

 

35

 

 

 

40

%

Impairment

 

908

 

 

 

 

 

 

908

 

 

N/A

 

 

 

908

 

 

 

 

 

 

908

 

 

N/A

 

Depreciation and amortization
   expense

 

53

 

 

 

36

 

 

 

17

 

 

 

47

%

 

 

132

 

 

 

76

 

 

 

56

 

 

 

74

%

Total costs and expenses

 

8,278

 

 

 

32,995

 

 

 

(24,717

)

 

 

-75

%

 

 

28,021

 

 

 

54,477

 

 

 

(26,456

)

 

 

-49

%

LOSS FROM OPERATIONS

 

(8,278

)

 

 

(32,995

)

 

 

24,717

 

 

 

-75

%

 

 

(28,021

)

 

 

(54,477

)

 

 

26,456

 

 

 

-49

%

NON-OPERATING INCOME (EXPENSE)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other income

 

13

 

 

 

29

 

 

 

(16

)

 

 

-55

%

 

 

49

 

 

 

39

 

 

 

10

 

 

 

26

%

Interest income

 

388

 

 

 

1

 

 

 

387

 

 

*

 

 

 

914

 

 

 

2

 

 

 

912

 

 

*

 

Derivative gain (loss)

 

 

 

 

 

 

 

 

 

N/A

 

 

 

11,743

 

 

 

 

 

 

11,743

 

 

N/A

 

Interest expense

 

(2,237

)

 

 

(1

)

 

 

(2,236

)

 

*

 

 

 

(5,043

)

 

 

(2

)

 

 

(5,041

)

 

*

 

Other expense

 

(1

)

 

 

(3

)

 

 

2

 

 

 

-67

%

 

 

(14

)

 

 

961

 

 

 

(975

)

 

 

-101

%

Total non-operating income
   (expense)

 

(1,837

)

 

 

26

 

 

 

(1,863

)

 

NM

 

 

 

7,649

 

 

 

1,000

 

 

 

6,649

 

 

*

 

NET INCOME (LOSS)

$

(10,115

)

 

$

(32,969

)

 

$

22,854

 

 

 

-69

%

 

$

(20,372

)

 

$

(53,477

)

 

$

33,105

 

 

 

-62

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

* Represents a percentage change greater
       than +/- 300%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Comparison of the three and nine months ended March 31, 2023 and 2022

Project expenses

Project expenses include drilling, plug and abandonment, site-preparation, engineering, consumables, testing and sampling, hydrology, permits, surveys, and other expenses associated with further progressing our project. For the nine months ended March 31 2023, project expenses decreased 16% versus the comparable period in 2022. The decrease was primarily due to a reduction in drilling activity specific to water monitoring wells ($6.4 million) and costs related to technical reports ($1.6 million) incurred in the comparable 2022 period. These decreases were partially offset by costs related to our plug and abandonment program ($5.1 million), increases in construction related insurance ($0.5 million) and other site related costs ($0.8 million) incurred during the current period. For the quarter ended March 31, 2023, project expenses decreased 38% primarily due to costs related to technical reports incurred during the quarter ended March 31, 2022, partially offset by increases in construction related insurance ($0.2 million) and site related costs ($0.7 million) incurred during the current quarter.

General and administrative expenses

The decrease in general and administrative expenses during the three and nine months ended March 31, 2023 was primarily driven by one-time costs incurred during the prior three and nine months periods related to the preparation of our Form-10, our reorganization, and consulting fees paid to Blue Horizon Advisors LLC for services provided ($25.6 million and $30.9 million, respectively). The absence of these costs during the current three and nine month periods were partially offset by an increase in salaries and benefits, and other employee related costs ($1.3 million and $4.1 million, respectively) resulting from an increase in headcount from 11 at June 30, 2021 to 48 at March 31, 2023. All employee costs across our business are currently accounted for within general and administrative expenses. Insurance costs increased $0.2 million and $0.9 million during the three and nine months ended March 31, 2023, respectively, as a result of our public company Director and Officer insurance which began in March 2022.

Non-operating (income) expense

The derivative gain (loss) during the three and nine months ended March 31, 2023 related to changes in fair value of the embedded conversion feature of our convertible notes that was required to be bifurcated and accounted for separately as a stand-alone derivative instrument during the quarter ended September 30, 2022. The unrealized gain during the nine months ended March 31, 2023, was primarily due to the decrease in our stock price to $11.63 at the termination date from $15.83 on August 26, 2022 (inception date). The provision resulting in the separate derivative accounting for the conversion feature expired on November 26, 2022. The expiration resulted in the transfer of the fair value of the convertible note derivative at expiration to additional paid-in capital and no future related gains or losses are expected.

19


 

The increase in interest income during the three and nine months ended March 31, 2023 was attributable to short-term investments (original maturities of three months or less) in highly liquid treasury bills and a certificate of deposit starting at the end of the quarter ending September 30, 2022. The weighted average interest rate earned on these investments was approximately 4.06% and 3.66 % for the three and nine months ended March 31, 2023, respectively.

Interest expense increased primarily due to the issuance of the convertible note on August 26, 2022 and includes $1.5 million and $3.5 million of debt issuance cost amortization during the three and nine months ended March 31, 2023, respectively. During the three and nine months ended March 31, 2023, we capitalized interest to construction in progress of approximately $392 thousand and $589 thousand, respectively. Interest expense for the three and nine months ended March 31, 2022 related to a note that was paid off during the year ended June 30, 2022.

Other expense consists primarily of foreign exchange gains and losses. The decrease during the three and nine months ended March 31, 2023 compared to the comparative period was due to the transfer and conversion to U.S. dollars of all foreign denominated cash balances during the quarter ended June 30, 2022 to our bank account in the U.S.

Income Tax

We did not have any income tax expense or benefit for the three and nine months ended March 31, 2023 and 2022, as we have recorded a full valuation allowance against our net deferred tax asset.

Liquidity and Capital Resources

As of March 31, 2023, we had cash and cash equivalents of $36.2 million and working capital of $26.6 million compared to $31.1 million and $25.2 million as of June 30, 2022, respectively. Our predominant source of cash has been generated through equity financing from issuances of our common stock and hybrid equity and debt securities. Since inception, we have not generated revenues, and as such, have relied on equity financing and hybrid equity and debt instruments to fund our operating and investing activities.

In August 2022, we executed a $60 million private placement of senior secured convertible notes to complete construction and commissioning of our Small-Scale Facility, fund operation of our Small-Scale Facility, commence detail engineering and procure long lead items for our large-scale complex and general corporate purposes.

With our current capital resources, we believe that we have sufficient funds to construct and commission our Small-Scale Facility; however, delay of final authorization to commence mining could push out operation of the facility until we raise additional capital. Over the next 12 months we have plans to do the following below that will require additional capital:

Operate the Small-Scale Facility;
Progress detailed engineering and procure long lead item equipment, specifically our crystallization units;
Optimize well-field design in an effort to reduce future mining capital and operational expenditure through various drilling techniques such as directional, horizontal and radial drilling;
Pursue and optimize infrastructure capital expenditures for our larger-scale facility which could include expansion of non-potable water resources, upgrading shore power, connection to a natural gas network, and constructing new access roads into and out of the location for our larger-scale facility;
Further define our advanced materials strategy with consideration to engineering and repurposing our Small-Scale Facility to produce boron advanced materials once sufficient data has been obtained for flow sheet optimization and the production of product for customer qualification; and
Continue hiring team members necessary to support our operation efforts of becoming a global producer of boric acid, lithium carbonate and gypsum.

As of today, we are currently operating under our most recently updated modified business plan until we secure additional financing. Absent additional financing as outlined above, we would no longer be able to meet our ongoing obligations or progress operations. If we are not able to procure other financing cash flows and our cash balance falls below $10 million, an event of default under the Convertible Note agreement would occur if not cured within 30 days. Our available liquidity is expected to fall below $10 million in the latter part of calendar year 2023 based on our most recently updated modified business plan. An event of default would cause our Convertible Note balance outstanding to become immediately due and payable, of which we would not have the resources to repay without additional financing. See Note 1 - Going Concern in the notes to the unaudited condensed consolidated financial statements.

 

20


 

Critical Accounting Policies

Derivative Financial Instruments

Our derivative instruments are accounted for on a mark-to-market basis. During the quarter ended December 31, 2022, our only derivative instrument, the convertible note derivative, was derecognized through a transfer to additional paid in capital. The derivative fair value was determined using a with-and-without methodology utilizing a binomial lattice model. The model considers various inputs including time value, volatility, credit risk and the current share price of our common stock. As a result, the value of the embedded conversion feature could be significantly different than the fair value transferred to additional paid in capital of $13.2 million, See Notes 7 and 8 to our unaudited condensed consolidated financial statements in item 1 of this report for additional information.

Contractual Commitments and Contingencies

Purchase Obligations

The Company had purchase order commitments $16.2 million for the construction works in progress, equipment, software and technical reports, of which $8.7 million is reflected in accounts payable and accrued liabilities on our unaudited condensed consolidated balance sheet at March 31, 2023. The majority of the commitments are expected to be settled by June 30, 2023.

Mineral Lease Payments

During the quarter ended March 31, 2023, we elected not to renew our mineral lease with Elementis Specialties, Inc. and the mineral lease expired on March 31, 2023 resulting in the recognition of approximately $908 thousand of related impairment expense during the current quarter. We determined that with increasing boric acid and lithium carbonate prices, sufficient mineral resource established on fee lands already owned by us, and the opportunity to further expand the mineral resource with additional exploration work at a later date, that there is sufficient mineral resource to fully execute on our long-term business plan of producing boric acid and lithium carbonate. The Company will be updating its Initial Assessment Report accordingly.

Salt Wells Earn-in Agreement

On August 2, 2022, Great Basin Resources, Inc. agreed to amend our Salt Wells Earn-in Agreement. To fully realize the mineral interest rights under the agreement, we must incur exploration expenses of $900 thousand by December 31, 2023, $800 thousand by December 31, 2024, and approximately $756 thousand by December 31, 2025.

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

Not required.

Item 4. Controls and Procedures.

During our fiscal year end June 30, 2022, management identified a material weakness in our internal control over financial reporting related to a lack of segregation of duties in the administrative rights of our accounting system. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis. During the nine month period ended March 31, 2023, we have taken steps towards remediating the design deficiency that led to the material weakness by hiring additional accounting personnel, removing the conflicting access to the old accounting system, and effective October 1, 2022, transitioned to a new more robust accounting system. During the quarter ended December 31, 2022, we finalized the design and implementation of the controls to address the material weakness, however, its required that controls operate effectively for a sufficient period of time and undergo testing before management concludes that the controls are operating effectively.

Our management, under supervision and with the participation of our Chief Executive Officer and our Chief Financial Officer , evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act) as of March 31, 2023. Based on the evaluation of our disclosure controls and procedures as well as the potential impact of the material weakness described above, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were ineffective as of March 31, 2023. Any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives.

Changes in Internal Control over Financial Reporting

Except as described above, there were no changes in internal control over financial reporting identified in the evaluation for the quarter ended March 31, 2023, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

21


 

PART II - OTHER INFORMATION

Item 1. Legal Proceedings.

As of March 31, 2023, we were not a party to any material legal proceedings.

Item 1A. Risk Factors.

In addition to the risk factors set out below and other information set forth in this Form 10-Q, you should carefully consider the factors discussed in Part 1, Item 1A. “Risk Factors” in our annual report on Form 10-K, which could materially affect our business, financial condition, and future results. The risks described in our Form 10-K are not the only risks that we face. Additional risk and uncertainties not currently known to us or that we currently deem to be immaterial may also materially adversely affect our financial condition, operating results and cash flows.

 

There is substantial doubt regarding our ability to continue as a going concern. We will need to raise substantial additional funding, which may not be available on acceptable terms, if at all, to be able to continue as a going concern and advance our Project.

There is substantial doubt regarding our ability to continue as a going concern. Our existence in our current form is dependent upon our ability to obtain additional capital. As of March 31, 2023, we had cash and cash equivalents of approximately $36.2 million which we believe will not be sufficient to fund our operating expenses and capital requirements for one year after the date that the financial statements are issued. Raising funds in the current economic environment is challenging and financing may not be available in sufficient amounts or on acceptable terms, if at all. The issuance of additional securities, whether equity or debt, or the possibility of such issuance, may cause the market price of our shares to decline. The sale of additional equity or debt securities may dilute the ownership of existing shareholders.

Government efforts to combat inflation, along with other interest rate pressures arising from an inflationary economic environment, could lead to higher financing and project completion costs.

Inflation has risen on a global basis, the United States has been experiencing historically high levels of inflation, and government entities have taken various actions to combat inflation, such as raising interest rate benchmarks. Government entities may continue their efforts, or implement additional efforts, to combat inflation, which could include among other things continuing to raise interest rate benchmarks or maintaining interest rate benchmarks at elevated levels. Such government efforts, along with other interest rate pressures arising from an inflationary economic environment, could lead to higher financing costs and have material adverse effect on our business, financial condition and results of operations.

Our business could be affected by macroeconomic risks.

The Company’s operations and performance depend significantly on global and regional economic conditions. Macroeconomic conditions, including inflation, slower growth or recession, changes to fiscal and monetary policy, tighter credit, higher interest rates, high unemployment and currency fluctuations can materially adversely affect demand for the Company’s products and services. In addition, confidence and spending can be materially and adversely affected in response to financial market volatility, negative financial news, declines in income or asset values, energy shortages and cost increases, labor and healthcare costs and other economic factors. An adverse impact on demand for the Company’s products, uncertainty about, or a decline in, global or regional economic conditions can have a significant impact on the Company’s suppliers and other partners. Potential effects include financial instability; inability to obtain credit to finance operations and purchases of the Company’s products; and insolvency. We cannot predict the timing or scale of these various macroeconomic conditions, but they could have a material adverse affect on our business, results of operations and financial condition.

The transition to a new Chief Executive Officer (“CEO”) will be critical to our success and our business may be adversely impacted if we do not successfully manage the transition process in a timely manner.

Our success depends, in part, on the effectiveness of our interim Principal Executive Officer, and the effective transition to our new permanent CEO in April. The new CEO will be critical to executing on and achieving our vision, strategic direction, culture, products, and technology. If we are unable to execute an orderly transition and successfully integrate the new CEO into our leadership team, our operations and financial conditions may be adversely affected.

Additionally, the departure of our CEO has resulted in a loss of institutional knowledge. This loss of knowledge and experience can be mitigated through successful hiring and transition, but there can be no assurance that we will be successful in such efforts. The ability of the new CEO to quickly adapt to and understand our business, operations, and strategic plans will be critical to the Board and our management’s ability to make informed decisions about our strategic direction and operations.

 

22


 

We have experienced significant turnover in our senior management team and across our organization, and our failure to attract and retain qualified personnel, skilled workers and key officers could have an adverse effect on us.

Our business may be adversely affected by recent turnover in our senior management team and board of directors which may create instability within the Company, which could disrupt and impede our day-to-day operations, internal controls and our ability to fully implement our business plan and growth strategy. In addition, management transition inherently causes some loss of institutional knowledge, which can negatively affect strategy and execution, and our results of operations and financial condition could be negatively impacted as a result. Competition for key management personnel is intense. If we fail to successfully attract and appoint permanent replacements with the appropriate expertise, we could experience increased employee turnover and harm to our business, results of operations, cash flow and financial condition. The search for permanent replacements could also result in significant recruiting and relocation costs, as well as increased salary and benefit costs. Like most businesses, our employees are important to our success and we are dependent in part on our ability to retain the services of our key management, operational, compliance, finance and administrative personnel. In order to compete and implement our growth strategy, we must attract, retain, and motivate employees, and turnover of senior management may make it difficult to retain qualified and skilled employees.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

Date

 

Title of Security

 

Number

 

 

Consideration Received

 

 

Exemption from Registration Claimed

 

Security Holder

10/18/2022

 

Common Stock

 

 

100,000

 

(1)

$

365,000

 

 

Section 4(a)(2)

 

Aaron Dean Bertolatti <ATF Bertolatti Family Trust>

10/20/2022

 

Common Stock

 

 

100,000

 

(1)

 

365,000

 

 

Section 4(a)(2)

 

irX Enterprises Pty Ltd <irX Trust>

10/21/2022

 

Common Stock

 

 

200,000

 

(1)

 

730,000

 

 

Section 4(a)(2)

 

JAWAF Enterprises Pty Ltd <Hall Family A/C>

10/24/2022

 

Common Stock

 

 

100,000

 

(1)

 

365,000

 

 

Section 4(a)(2)

 

Scor Go Luath Limited

1/13/2023

 

Common Stock

 

 

150,000

 

(1)

 

768,000

 

 

Section 4(a)(2)

 

BJS Robb Pty Ltd

 

 

 

 

 

650,000

 

 

$

2,593,000

 

 

 

 

 

(1) shares issued upon option exercises

The transactions listed above are exempt from registration pursuant to Section 4(a)(2) of the Securities Act.

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosures.

Not applicable because we do not currently operate any mines subject to the U.S. Federal Mine Safety and Health Act of 1977.

Item 5. Other Information.

None.

 

 

23


 

 

Item 6. Exhibits.

Exhibit Index

Exhibit
Number

Description

   10.1

Brennan Employment Agreement (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on March 20, 2023)

  31.1*

Certification of Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

  31.2*

Certification of Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

  32.1*

Certification of Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

  32.2*

Certification of Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101.INS*

XBRL Instance Document - embedded within the Inline XBRL document

101.SCH*

XBRL Taxonomy Extension Schema Document

101.CAL*

XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF*

XBRL Taxonomy Extension Definition Linkbase Document

101.LAB*

XBRL Taxonomy Extension Label Linkbase Document

101.PRE*

XBRL Taxonomy Extension Presentation Linkbase Document

104*

Cover page Interactive Data file (formatted as Inline XBRL and contained in Exhibit 101).

* Filed herewith.

 

24


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

5E Advanced Materials, Inc.

(Registrant)

Date: May 15, 2023

By:

/s/ Paul Weibel

Paul Weibel

Chief Financial Officer (Principal Financial Officer)

 

25